Georgia's life sciences sector could benefit from BIO event

05/18/2009 | American City Business Journals

Georgia's life sciences companies could gain about $300 million during the next 10 years from licensing agreements, strategic partnerships and fundraising as the state hosts this year's BIO International Convention in Atlanta, said Georgia Bio CEO Charles Craig. Atlanta's infrastructure and compatibility with BIO's strategy to drive the event around the U.S. are the reasons why the trade group chose the city over Raleigh, N.C., said Jim Greenwood, BIO's president and CEO.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI